Birgit C. Schultes serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Birgit C. Schultes has executed 2 insider transactions totaling $78.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved selling 8,508 shares valued at $78.4K.
Birgit C. Schultes currently holds 98,533 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Birgit C. Schultes has been a net seller of NTLA stock. They have purchased $0 and sold $78.9K worth of shares.
Birgit C. Schultes's most recent insider trade was on Jan 5, 2026, when they sold 8,508 shares at $9.21 per share.
Get notified when new Form 4 filings are submitted
| $17.38 |
| Discretionary |